Drug Type Small molecule drug |
Synonyms Heptaplatin, Sunpla, NSC 644591 + [5] |
Target |
Mechanism DNA inhibitors(DNA inhibitors), DNA alkylating agents |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date KR (20 Jul 1993), |
Regulation- |
Molecular FormulaC11H20N2O6Pt |
InChIKeyXJXKGUZINMNEDK-GPJOBVNKSA-L |
CAS Registry146665-77-2 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Neoplasms | KR | 14 Nov 1999 | |
Head and Neck Neoplasms | KR | 01 Jul 1999 | |
Lung Cancer | KR | 01 Jul 1999 | |
Uterine Cervical Cancer | KR | 01 Jul 1999 | |
Stomach Cancer | KR | 20 Jul 1993 |
Phase 1/2 | - | oxqxufkagq(dafqryhzew) = rerfyvgzgf dxkezmmmvd (qywogmqaaf ) View more | - | 01 Jun 2005 | |||
Phase 1 | 30 | vtxcbdliei(iblskknrhu) = G3 proteinuria zcmeundlct (aibjrqrizx ) | - | 01 Jun 2005 | |||
Phase 1 | 15 | pgclbkhiqe(eowkbxfgnj) = myelosuppression and hepatotoxicity hdhxqvandq (zuvgecghic ) | - | 15 Jul 2004 |